EBGCR Clinical Research Principal Investigators Provide Exceptional Care

Principal Investigators at EBGCR
Photo of Ali Lankarani M.D.

Ali Lankarani, M.D.

Gastroenterologist Encore Borland Groover Clinical Research
4800 Belfort Road Jacksonville FL 32256 Contact Research: (904) 680-0871

Biography

Dr. Lankarani joined Borland Groover in 2012 from the Mayo Clinic hospital. He moved to Jacksonville from Pittsburgh after finishing his training in gastroenterology at the Drexel University- West Penn Allegheny Health System. Dr. Lankarani studied internal medicine at the Johns Hopkins University-Sinai Hospital of Baltimore.

Dr. Lankarani is a member of the Advanced Therapeutic Endoscopy Center (ATEC) at Borland Groover and performs advanced endoscopic procedures for diagnosis and treatment of pre-cancerous and early cancers of gastrointestinal tract. His is especially interested in endoscopic treatment of gastroesophageal reflux disease (GERD) and has been the lead investigator on the international multi-center study for endoscopic anterior fundoplication using MUSE system. His research interest mainly involves development of a new classification system used for personalized endoscopic treatment of GERD.



Eosinophilic esophagitis EoE

 


Postgraduate Education

2005 – 2008
Internal Medicine Resident
Johns Hopkins University/Sinai Hospital Program in Internal Medicine

2008 – 2011
Post-Doctoral Fellow in Clinical Gastroenterology/Hepatology
Allegheny General Hospital/Drexel University College of Medicine

2011 – 2012
Advanced Endoscopy Fellow / Clinical Instructor
Mayo Clinic Hospital

PATENTS:
2001 Optical Feet Shape Recognizer (O.F.S.R.)
Patent and Trademark Office, Tehran, Iran

RESEARCH TRAINING:
4/13/2018 CITI Good Clinical Practice Course
6/10/2016 TransCelerate ICH GCP
6/6/2014 TransCelerate ICH GCP

RESEARCH EXPERIENCE:

Principal Investigator:
2020-Present Allakos AK002-014, Eosinophilic Esophagitis 2020-Present Allakos AK002-016, Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
2020-Present Allakos AK002-019, Prospective Eosinophilic Gastrointestinal Diseases
2015 A Worldwide Post-Market Surveillance Registry to assess the Medigus Ultrasonic Surgical Endostapler (MUSE™) System for the treatment of GERD
2009 PEEP trial (Pittsburgh Endoscopic Ultrasound Evaluation of Pancreatic Cysts). PEEP trial is the first multi-centered, controlled prospective study for evaluation of pancreatic cyst cytology via EUS with standard FNA vs. standard FNA and EchoBrush.
Allegheny General Hospital/Drexel University College of Medicine, Pittsburgh, PA
2006 Designed and performed a clinical study for evaluation of optimal multidisciplinary health screening and management of Diabetes Mellitus in resident continuity clinic.
Sinai Hospital of Baltimore, Maryland
2005 Assessment of angioplasty for treatment of Carotid artery stenosis in high risk patients.
Midatlantic Cardiovascular Associates, Maryland

Sub-Investigator:
2020-Present Neurogastrx NG101-201, Gastroparesis
2019-Present Gilead GS-US-337-1431, Hepatitis C
2017 KC Specialty NI03-001, Chronic Pancreatitis
2015 Cook 10-014 Evaluation of the Effectiveness of Evolution® Biliary Stent System – Fully Covered
2014 Beacon FNA-EUS Comparative effectiveness of fixed-number versus cytopathologist/ cytotechnologist-guided endoscopic ultrasound guided fine needle aspiration of pancreatic solid mass

PROFESSIONAL ASSOCIATIONS:

2010-2011 Fellow in Training Board Member, Pennsylvania Society of Gastroenterology

2010-2011 Member, Ethics committee of Allegheny General Hospital, Pittsburgh

2009-2011 Member, GI Fellowship Curriculum Development Board, Allegheny General Hospital, Pittsburgh

2007-2011 Trainee Member, American Society for Gastrointestinal Endoscopy

2006-2011 Trainee Member, American Gastroenterological Association

2006-2011 Trainee Member, American College of Gastroenterology

2005-2007 Member, Residency Advisory Committee, Johns Hopkins University/Sinai Hospital Program in Internal Medicine

HONORS AND AWARDS:

2011 Research scholarship award, to attend PancreasFest 2011, Pittsburgh, Pennsylvania

2011 Scholarship award to attend the 8th Pan-Arab Conference on Gastroenterology and the 11th Conference of the Saudi Gastroenterology Association, Riyadh, Kingdom of Saudi Arabia

2010 Recipient, Emerging Star Award, 12th International Workshop on Therapeutic Endoscopy, Cairo

2010 Scholarship, to attend the “3rd Hepatology & Gastroenterology Post Graduate Course and 12th International Workshop on Therapeutic Endoscopy at Cairo”

2010 Scholarship, to attend the “18th International Symposium on Pancreatic and Biliary Endoscopy at Cedars-Sinai Medical Center”

2010 Scholarship, to attend the “Boston International Live Endoscopy Course”

2009-2010 Scholarship, National Pancreatic Foundation to attend the “NPF Fellow Symposium”

2008 Scholarship, to attend the “Mayo Clinic Endoscopy live – 2008”

2006 Recipient, Albert I. Mandeloff Research Award for Outstanding Contributions to the Basic/Clinical Science of Gastroenterology.

2006 Finalist, Maryland Society of Gastrointestinal Endoscopy Annual Award

2004 Kaplan Honor Society, U.S.A.

2002 International Young Inventor Award of Kharazmi, Iran

2001 First Dissertation Award, Tehran, Iran

2001 Outstanding Chief Intern, Taleghani Hospital, Iran

DISSERTATION:

2001 Optical Feet Shape Recognizer (O.F.S.R); A New Imaging Device for Diagnosis of Feet Shape Anomalies

Designed and constructed a novel optical imaging instrument that detected various pedal anomalies based upon measurements of pressure points and surface contact areas of the feet.

Lankarani AM, Wallace MB, Endoscopic ultrasonography/fine-needle aspiration and endobronchial ultrasonography/fine-needle aspiration for lung cancer staging, Gastrointest Endosc Clin N Am. 2012 Apr;22(2):207-19

Lankarani AM, Wallace MB, ESD-EMR: the Western endoscopist’s point of view. Italian Journal of Digestive Endoscopy. 2012 June

Lankarani AM, Oustecky D, New Media and Gastroenterology Training, Spring 2010 PSG Newsletter

Lankarani AM, Agrawal R, Dhawan M. Gastric Carcinoma Concealed by Paraesophageal Hernia: Case report and review of the literature. The Internet Journal of Gastroenterology, 2010 – Volume 9 Number 2

Lankarani AM, Oustecky D. Rising Stars Poster Competition event reporting from Pennsylvania Society of Gastroenterology Annual Scientific Meeting. Fall 2010 Newsletter
Abstracts

Lankarani AM, Wallace MB, Polarization Gating Spectroscopy of Apparently Normal Duodenal Mucosa to Detect Pancreatic Cancer, Gastrointestinal Endoscopy Vol. 75, 4, AB162,2012

Lankarani AM , Lukens F. Double Balloon Enteroscopy in Patients With Surgically Altered Bowel Anatomy: Analysis of Large Prospectively Collected Database, Gastroenterology Vol. 142, 5, S-1082,2012

Lankarani AM , Lukens F.Small Bowel Tumors Discovered During Double Balloon Enteroscopy (DBE): Analysis of Large Prospectively Collected Database, Gastroenterology Vol. 142, 5, Pages S-759-S-760,2012

Lankarani AM, Timothy AW. Use of Aspirin or NSAIDs and Female Gender are Associated With Decreased Risk for Dysplasia on Large Sessile Colonic Polyps, Gastrointestinal Endoscopy Vol. 75, 4, AB410-AB41,2012

Lankarani AM, Timothy AW. Predictors of High Grade Dysplasia (HGD) or Adenocarcinoma (AC) on Endoscopic Mucosal Resection (EMR) of Large Colonic Polyps, Gastrointestinal Endoscopy Vol. 75, 4, AB499,2012

Lankarani AM, Dhawan M. Agreement between Onsite and Final Cytologic Interpretations of EUS-FNA, Gastrointestinal Endoscopy, Gastrointestinal Endoscopy Vol. 73, 4, AB251,2011

Lankarani AM, Dhawan M. Diagnosis of Pancreatic Cancer with EUSFNA: Factors That Influence Adequate Sampling, Gastrointestinal Endoscopy Vol. 73, 4, AB259,2011

Lankarani AM, Dhawan M. Detection of Metastasis during Staging EUS in Patients with Pancreaticobiliary Cancer, Gastrointestinal Endoscopy Vol. 73, 4, AB340,2011

Lankarani AM, Dhawan M. Agreement between Onsite and Final Cytologic Interpretations of EUS-FNA, The Saudi Journal of Gastroenterology. 17(2011):S1,2011

Lankarani AM, Dhawan M. Diagnosis of Pancreatic Cancer with EUSFNA: Factors That Influence Adequate Sampling,The Saudi Journal of Gastroenterology. 17(2011):S12,2011

Lankarani AM, Dhawan M. Detection of Metastasis during Staging EUS in Patients with Pancreaticobiliary Cancer, The Saudi Journal of Gastroenterology. 17(2011):S12,2011

Lankarani AM, Agrawal R, Dhawan M. Gastric Carcinoma Concealed by Paraesophageal Hernia: A Rare Manifestation of a Common Disease. The American Journal of Gastroenterology. 104 (2009):S579.

Lankarani AM, Thakkar S. Isolated Jejunal Graft-Versus-Host-Disease Following Peripheral Blood Stem Cell Transplantation. The American Journal of Gastroenterology. 104 (2009):S751.

Lankarani AM, Dutta SK. Successful Endoscopic Dilation of Cervical Webs: Two Case Reports. The American Journal of Gastroenterology. 102 (2007): S386.

Lankarani AM, Dutta SK. Giant Hyperplastic Gastric Polyps: Precursor to Adenocarcinoma? The American Journal of Gastroenterology. 102 (2007): S401.

Lankarani AM, Chow D. Unusual Presentation of Pancreatitis. American College of Physicians (Abstract).

Abstracts:

Lankarani AM, Wallace MB, Polarization Gating Spectroscopy of Apparently Normal Duodenal Mucosa to Detect Pancreatic Cancer, Gastrointestinal Endoscopy Vol. 75, 4, AB162

Lankarani AM , Lukens F. Double Balloon Enteroscopy in Patients With Surgically Altered Bowel Anatomy: Analysis of Large Prospectively Collected Database, Gastroenterology Vol. 142, 5, S-1082

Lankarani AM , Lukens F.Small Bowel Tumors Discovered During Double Balloon Enteroscopy (DBE): Analysis of Large Prospectively Collected Database, Gastroenterology Vol. 142, 5, Pages S-759-S-760

Lankarani AM, Timothy AW. Use of Aspirin or NSAIDs and Female Gender are Associated With Decreased Risk for Dysplasia on Large Sessile Colonic Polyps, Gastrointestinal Endoscopy Vol. 75, 4, AB410-AB41

Lankarani AM, Timothy AW. Predictors of High Grade Dysplasia (HGD) or Adenocarcinoma (AC) on Endoscopic Mucosal Resection (EMR) of Large Colonic Polyps, Gastrointestinal Endoscopy Vol. 75, 4, AB499

Lankarani AM, Dhawan M. Agreement between Onsite and Final Cytologic Interpretations of EUS-FNA, Gastrointestinal Endoscopy, Vol. 73, Issue 4, AB251

Lankarani AM, Dhawan M. Diagnosis of Pancreatic Cancer with EUS-FNA: Factors That Influence Adequate Sampling, Gastrointestinal Endoscopy, Vol. 73, Issue 4, AB259

Lankarani AM, Dhawan M. Detection of Metastasis during Staging EUS in Patients with Pancreaticobiliary Cancer, Gastrointestinal Endoscopy, Vol. 73, Issue 4, AB340

Lankarani AM, Dhawan M. Agreement between Onsite and Final Cytologic Interpretations of EUS-FNA, The Saudi Journal of Gastroenterology. 17(2011):S1

Lankarani AM, Dhawan M. Diagnosis of Pancreatic Cancer with EUS-FNA: Factors That Influence Adequate Sampling,The Saudi Journal of Gastroenterology. 17(2011):S12

Lankarani AM, Dhawan M. Detection of Metastasis during Staging EUS in Patients with Pancreaticobiliary Cancer, The Saudi Journal of Gastroenterology. 17(2011):S12

Lankarani AM, Agrawal R, Dhawan M. Gastric Carcinoma Concealed by Paraesophageal Hernia: A Rare Manifestation of a Common Disease. The American Journal of Gastroenterology. 104 (2009):S579.

Lankarani AM, Thakkar S. Isolated Jejunal Graft-Versus-Host-Disease Following Peripheral Blood Stem Cell Transplantation. The American Journal of Gastroenterology. 104 (2009):S751.

Lankarani AM, Dutta SK. Successful Endoscopic Dilation of Cervical Webs: Two Case Reports. The American Journal of Gastroenterology. 102 (2007): S386.

Lankarani AM, Dutta SK. Giant Hyperplastic Gastric Polyps: Precursor to Adenocarcinoma? The American Journal of Gastroenterology. 102 (2007): S401.

Lankarani AM, Chow D. Unusual Presentation of Pancreatitis. American College of Physicians (Abstract).

Exceptional care provided by EBGCR Clinical Research Principal Investigators

The Clinical Research Principal Investigators at Encore Borland Groover Clinical Research (EBGCR) strive to improve patient outcomes through cutting-edge clinical research. Our team of world-renowned specialists is committed to transforming medicine by conducting groundbreaking clinical trials. Our Clinical Research Principal Investigators are leaders in pharmacologic outcome clinical trials, particularly with new agents in Phases I-III. Our esteemed physicians can provide patients with early access to pioneering drugs by conducting clinical trials, which may only be available to the general public for a short time. With extensive clinical research expertise, our team advances medical knowledge daily and addresses serious health issues to enhance people’s lives today and tomorrow.

At EBGCR, we understand that the success of our clinical trials depends on having a team of experts dedicated to ensuring the highest research standards. Among these experts are our EBGCR Clinical Research Principal Investigators, who play a fundamental role in overseeing and guiding our studies. These experienced professionals bring a wealth of knowledge and expertise to our team, with a deep understanding of the intricacies of clinical research. Our investigators help us design and execute trials that meet the highest quality and safety standards by working closely, providing our patients with the best possible care and outcomes.

EBGCR Clinical Research Principal Investigators

904-680-0871

Contact us today

Expertise provided by Clinical Research Principal Investigators

At the heart of our mission to improve lives lies the expertise and dedication of our EBGCR Clinical Research Principal Investigators. Our entire team has a wealth of knowledge, experience, and passion for making a real difference in the world of healthcare; our investigators are committed to discovering and developing the life-saving treatments that will revolutionize how we approach patient care. Drawing on the latest advancements in medical research, our team is continually looking forward to the future of healthcare, exploring new and innovative ways to improve outcomes and unlock new possibilities for patients worldwide. At EBGCR, we believe that together, we can make a real difference in the lives of those we serve, and we are committed to doing everything we can to bring our mission of improved healthcare to energy.